The store will not work correctly when cookies are disabled.
Sodium salt (5R,6R)-6-aminomethyl-3-tert-butyl-7-oxo-4-oxa-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
ID: ALA415245
PubChem CID: 44310213
Max Phase: Preclinical
Molecular Formula: C11H15N2NaO4
Molecular Weight: 240.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)C1=C(C(=O)[O-])N2C(=O)[C@H](CN)[C@H]2O1.[Na+]
Standard InChI: InChI=1S/C11H16N2O4.Na/c1-11(2,3)7-6(10(15)16)13-8(14)5(4-12)9(13)17-7;/h5,9H,4,12H2,1-3H3,(H,15,16);/q;+1/p-1/t5-,9+;/m0./s1
Standard InChI Key: YOUMPOQQCPCSKC-XEDRIYAZSA-M
Molfile:
RDKit 2D
19 19 0 0 0 0 0 0 0 0999 V2000
4.3792 -8.2792 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
5.4292 -6.7542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2167 -7.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4292 -5.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -6.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7042 -6.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -5.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2042 -5.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4792 -7.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5167 -6.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -7.3417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -8.5792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2792 -7.9542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -5.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2292 -4.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8917 -7.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5917 -5.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2917 -6.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2666 -4.9425 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 2 1 0
5 2 1 0
6 3 2 0
7 5 1 0
4 8 1 0
9 3 1 0
10 6 1 0
11 5 2 0
12 9 1 0
13 9 2 0
7 14 1 6
15 14 1 0
16 10 1 0
17 10 1 0
18 10 1 0
4 7 1 0
6 8 1 0
4 19 1 6
M CHG 2 1 1 12 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 240.26 | Molecular Weight (Monoisotopic): 240.1110 | AlogP: 0.10 | #Rotatable Bonds: 2 |
Polar Surface Area: 92.86 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.90 | CX Basic pKa: 9.01 | CX LogP: -2.74 | CX LogD: -2.74 |
Aromatic Rings: ┄ | Heavy Atoms: 17 | QED Weighted: 0.67 | Np Likeness Score: 0.72 |
References
1. Wild H, Metzger K. (1993) Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization, 3 (11): [10.1016/S0960-894X(01)80926-4] |